Summary

Concert Pharmaceuticals Inc

Founded in 2006

Description

Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates. The company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. Their product candida...

Strengths

  • Concert Pharmaceuticals Inc has a strong market share in their industry
  • Since Concert Pharmaceuticals Inc was founded, the company has grown faster than the industry average

Weaknesses

  • Revenue generated per employee is less than the industry average
  • Revenue growth is less than the industry average
  • The number of employees is not growing as fast as the industry average
  • Web traffic rankings are worse than the industry average

Annual Revenue

Concert Pharmaceuticals Inc's annual revenue

$32573000

Based on Kona Equity data

  • Revenue per employee

    $508953

  • Annual revenue growth since founding

    $1809611

  • Revenue growth rate from first known quarter to current

    -92.7%

Employee Count

64 employees

  • Employee growth rate from first known quarter to current

    10.9%

Executives

Christine Boisclair

Vice President, Regulatory Affairs & Quality Assurance

c**@concertpharma.com

Marc Becker

Chief Financial Officer

m**@concertpharma.com

Thomas Koperniak

Associate Director, Regulatory Affairs

t**@concertpharma.com

Gary Bridson

Principal Investigator Bioanalytical

g**@concertpharma.com

Rose Persichetti

Patent Agent

r**@concertpharma.com

Roger Tung

CEO

r**@concertpharma.com

John Lebo

Director, Finance

j**@concertpharma.com

Robert Zelle

Vice President and Senior Fellow

r**@concertpharma.com

John Kavouris

Chemical Development Scientist

j**@concertpharma.com

Meghan Barden

Documentation Specialist

m**@concertpharma.com

Darren Wong

Vice President, Pharmacology & Toxicology

d**@concertpharma.com

Pranav Raibagi

Senior Scientist

p**@concertpharma.com

Christopher Brummel

Vice President, Drug Metabolism, Pharmacokinetics and Bioanalysis

c**@concertpharma.com

Nancy Stuart

Chief Operating Officer

n**@concertpharma.com

Srinivas Tekkam

Senior Scientist

s**@concertpharma.com

Colleen Hamilton

Director, Clinical Operations

c**@concertpharma.com

Justine Koenigsberg

Senior VP, Corporate Communications & Investor Relations

j**@concertpharma.com

Clifton Leigh

Contractor In Manufacturing Process Chemistry

c**@concertpharma.com

Shaona Fang

Consultant

s**@concertpharma.com

Daniel Morse

Global Manager, Supply Chain

d**@concertpharma.com

Jeffrey Munsie

Chief Legal Officer

j**@concertpharma.com

Jennifer James

Senior Legal Contracts Administrator

j**@concertpharma.com

Cameron Cowden

Vice President, Pharmaceutical Development

c**@concertpharma.com

James Cassella

Chief Development Officer

j**@concertpharma.com

Andrew Knapp

Communications Senior Director, Medical

a**@concertpharma.com

Hiral Gujar

Formulation Co-op

h**@concertpharma.com

Kimberly Mack

Senior Director, Human Resources

k**@concertpharma.com

Mark Russett

Senior Director, Intellectual Property

m**@concertpharma.com

Virginia Braman

Clinical Operations Senior Advisor

v**@concertpharma.com

G Score - 2

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G6 Annual revenue growth since founding is higher than the industry average.

Web Analysis

  • Rank

    3.17 M

  • Page views per visitor

    1.0

Location

99 Hayden Avenue, Suite 500 
Lexington, Massachusetts  02421

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Calithera Biosciences Inc

calithera.com
  • Founded in 2010
  • Location: South San Francisco, CA
  • Annual Revenue: $9.8M
  • Employees: 63
  • Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer.

GlycoMimetics

glycomimetics.com
  • Founded in 2003
  • Location: Rockville, MD
  • Annual Revenue: $104.0K
  • Employees: 52
  • GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...

ArQule , Inc.

arqule.com
  • Founded in 1993
  • Location: Burlington, MA
  • Annual Revenue: $2.4M
  • Employees: 34
  • ArQule, Inc. is a clinical stage biotechnology company engaged in the research and development of cancer therapeutics. The Company is focused on developing small molecule drugs that target specific biological pathways implicated in various cancers and ...

Rigel Pharmaceuticals Inc

rigel.com
  • Founded in 1989
  • Location: South San Francisco, CA
  • Annual Revenue: $77.5M
  • Employees: 165
  • Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of novel, targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology. Rigel's pioneering research focuses on signa...

Lumos Pharma

lumos-pharma.com
  • Founded in 1999
  • Location: Austin, TX
  • Annual Revenue: $341.0K
  • Employees: 32
  • Lumos Pharma is a clinical stage biopharmaceutical company based in Austin, Texas. Their mission is to develop new therapies for people with rare diseases. They prioritize their focus on areas where the medical need is high and the pathophysiology is c...

UroGen Pharma

urogen.com
  • Location: Princeton, NJ
  • Annual Revenue: $54.1M
  • Employees: 192
  • UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated because patients deserve better options. Our vision is grounded in our RTGel drug delivery technology, our pr...

Key Information

  • SIC: 28; 283
  • NAICS: 32541; 5417
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Concert Pharmaceuticals Inc.

See similar companies

Frequently Asked Questions

Where is Concert Pharmaceuticals Inc located?

Concert Pharmaceuticals Inc's headquarters are located at 99 Hayden Avenue, Suite 500  Lexington, Massachusetts  02421.


What is Concert Pharmaceuticals Inc's official website?

Concert Pharmaceuticals Inc's official website is concertpharma.com


What is Concert Pharmaceuticals Inc's revenue?

Concert Pharmaceuticals Inc's annual revenue is $32.6 M.


What is Concert Pharmaceuticals Inc's SIC code?

Concert Pharmaceuticals Inc's SIC: 28; 283


What is Concert Pharmaceuticals Inc's NAICS code?

Concert Pharmaceuticals Inc's NAICS: 32541; 5417.


How many employees does Concert Pharmaceuticals Inc's have?

Concert Pharmaceuticals Inc has 64 employees


What industry does Concert Pharmaceuticals Inc belong to?

Concert Pharmaceuticals Inc is in the industry of Pharmaceuticals.

Next step

Visitors review